Edward Winnick

Our newest team member @JessicaKimCohen reports on startup Geneial's efforts to match rare genetic disease research with collected patient data.https://t.co/B2YveBa647

RT @NHGRI_Director: Today’s #NobelPrize winner Svante Pääbo is a true authority on the study of ancient DNA. He was the first to successful…

RT @NobelPrize: BREAKING NEWS: The 2022 #NobelPrize in Physiology or Medicine has been awarded to Svante Pääbo “for his discoveries concer…

ICYMI: https://t.co/qBl7odRa1C

RT @GenomeWeb: Metabolon, University of Oxford Parkinson's Disease Centre Strike Research Partnership. The collaborators hope that understa…

Really is amazing to see the disconnect between the positive reflections from Dr. Fauci's colleagues versus the guys writing in opinion pages about how their ability to make more money during the pandemic was harmed by his actions.

RT @RickABright: Not surprising…will get worse as virus becomes more prevalent & evolves. This is what happens when a new virus emerges in…

RT @PrecOncNews: IDRx Launches With Back-to-the-Future Combination Drug Development Strategy. The startup's founders are out to prove the p…

RT @PrecOncNews: GSK Waives Rights to Ideaya's MAT2A Inhibitor IDE397. Even though GSK won't exclusively license IDE397, Ideaya will contin…

The amendment would exempt tests developed at academic medical centers from regulation under VALID, but industry and other members of Congress haven't shown much interest. https://t.co/EAXOx7FjTC

ICYMI ...@ForestRay8 and @huanjia_zhang report on researchers efforts to use nanowire sequencing for epigenetic liquid biopsy testing. https://t.co/dVem3eazaB

Eric Schadt is leaving Sema4 immediately as the company cuts staff and moves its hereditary cancer testing business to Maryland. https://t.co/PBjDSm4tM6

RT @360DxNews: Roche Readies COVID-19 T-Cell Test to Determine Patient Immune Response. The company anticipates launching the test in the c…

Andy Han reports on the challenges facing Illumina as the firm posted a loss of legal expenses and lowered its guidance. (sub required) https://t.co/CZNFiqDtcZ